| Interpro ID | IPR013783 |
| Name | Ig-like_fold |
| Description | Immunoglobulin-like fold |
| Cross References | G3DSA:2.60.40.10 |
| Gene Symbol | Description | Entrez ID | Uniprot ID | Chromosomal Location |
|---|---|---|---|---|
|
KIAA0922 |
KIAA0922 |
23240 |
A2VDJ0 |
chr4: 153,466,346-153,636,711 |
|
SMCHD1 |
structural maintenance of chromosomes flexible hinge domain containing 1 |
23347 |
A6NHR9 |
chr18: 2,655,738-2,805,017 |
|
IGLL5 |
immunoglobulin lambda-like polypeptide 5 |
100423062 |
B9A064 |
chr22: 22,887,780-22,896,107 |
|
BTN3A3 |
butyrophilin subfamily 3 member A3 |
10384 |
O00478 |
chr6: 26,440,472-26,453,415 |
|
CHL1 |
cell adhesion molecule L1-like |
10752 |
O00533 |
chr3: 196,596-409,417 |
|
ISLR |
immunoglobulin superfamily containing leucine-rich repeat |
3671 |
O14498 |
chr15: 74,173,671-74,176,872 |
|
NCAN |
neurocan |
1463 |
O14594 |
chr19: 19,211,973-19,252,233 |
|
PLXNB2 |
plexin B2 |
23654 |
O15031 |
chr22: 50,274,979-50,307,627 |
|
SEMA3E |
sema domain, immunoglobulin domain (Ig), short basic domain, secreted, (semaphorin) 3E |
9723 |
O15041 |
chr7: 83,363,906-83,649,010 |
|
MUSK |
muscle, skeletal, receptor tyrosine kinase |
4593 |
O15146 |
chr9: 110,668,771-110,801,620 |
|
MID1 |
midline 1 |
4281 |
O15344 |
chrX: 10,445,310-10,833,654 |
|
NCAM2 |
neural cell adhesion molecule 2 |
4685 |
O15394 |
chr21: 20,998,315-21,543,329 |
|
FLRT2 |
fibronectin leucine rich transmembrane protein 2 |
23768 |
O43155 |
chr14: 85,530,144-85,654,426 |
|
PLXNC1 |
plexin C1 |
10154 |
O60486 |
chr12: 94,148,723-94,307,675 |
|
MPZL2 |
myelin protein zero-like 2 |
10205 |
O60487 |
chr11: 118,253,403-118,264,536 |
|
FCMR |
Fc fragment of IgM receptor |
9214 |
O60667 |
chr1: 206,904,386-206,923,247 |
|
SRPX2 |
sushi-repeat containing protein, X-linked 2 |
27286 |
O60687 |
chrX: 100,644,166-100,675,788 |
|
FCGR3B |
Fc fragment of IgG, low affinity IIIb, receptor (CD16b) |
2215 |
O75015 |
chr1: 161,623,196-161,631,963 |
|
PLXNA2 |
plexin A2 |
5362 |
O75051 |
chr1: 208,022,242-208,244,320 |
|
MFAP3L |
microfibrillar associated protein 3 like |
9848 |
O75121 |
chr4: 169,986,597-170,033,031 |
|
OBSL1 |
obscurin-like 1 |
23363 |
O75147 |
chr2: 219,550,729-219,571,859 |
|
SEMA7A |
semaphorin 7A, GPI membrane anchor (John Milton Hagen blood group) |
8482 |
O75326 |
chr15: 74,409,289-74,434,467 |
|
CILP |
cartilage intermediate layer protein |
8483 |
O75339 |
chr15: 65,194,758-65,211,488 |
|
FLNB |
filamin B |
2317 |
O75369 |
chr3: 58,008,400-58,172,251 |
|
MYCBP2 |
MYC binding protein 2, E3 ubiquitin protein ligase |
23077 |
O75592 |
chr13: 77,044,655-77,327,050 |
|
CEACAM4 |
carcinoembryonic antigen-related cell adhesion molecule 4 |
1089 |
O75871 |
chr19: 41,618,971-41,627,074 |
|
LRIG2 |
leucine-rich repeats and immunoglobulin-like domains 2 |
9860 |
O94898 |
chr1: 113,073,209-113,132,260 |
|
NFAT5 |
nuclear factor of activated T-cells 5, tonicity-responsive |
10725 |
O94916 |
chr16: 69,565,094-69,704,666 |
|
SEMA3D |
sema domain, immunoglobulin domain (Ig), short basic domain, secreted, (semaphorin) 3D |
223117 |
O95025 |
chr7: 84,995,553-85,186,855 |
|
UNC5C |
unc-5 netrin receptor C |
8633 |
O95185 |
chr4: 95,162,504-95,549,206 |
|
EPM2A |
epilepsy, progressive myoclonus type 2A, Lafora disease (laforin) |
7957 |
O95278 |
chr6: 145,382,535-145,736,023 |
|
VAPB |
VAMP (vesicle-associated membrane protein)-associated protein B and C |
9217 |
O95292 |
chr20: 58,389,122-58,451,101 |
|
MPZL1 |
myelin protein zero-like 1 |
9019 |
O95297 |
chr1: 167,721,192-167,791,919 |
|
PAPLN |
papilin, proteoglycan-like sulfated glycoprotein |
89932 |
O95428 |
chr14: 73,237,497-73,274,640 |
|
NFATC1 |
nuclear factor of activated T-cells, cytoplasmic, calcineurin-dependent 1 |
4772 |
O95644 |
chr18: 79,395,856-79,529,325 |
|
PPP1R3D |
protein phosphatase 1 regulatory subunit 3D |
5509 |
O95685 |
chr20: 59,936,668-59,940,297 |
|
F13A1 |
coagulation factor XIII, A1 polypeptide |
2162 |
P00488 |
chr6: 6,144,085-6,321,013 |
|
A2M |
alpha-2-macroglobulin |
2 |
P01023 |
chr12: 9,067,664-9,116,229 |
|
C3 |
complement component 3 |
718 |
P01024 |
chr19: 6,677,704-6,730,562 |
|
CD4 |
CD4 molecule |
920 |
P01730 |
chr12: 6,786,858-6,820,808 |
|
IGKC |
immunoglobulin kappa constant |
3514 |
P01834 |
chr2: 88,857,161-88,857,683 |
|
IGHG1 |
immunoglobulin heavy constant gamma 1 (G1m marker) |
3500 |
P01857 |
chr14: 105,736,343-105,743,071 |
|
IGHM |
immunoglobulin heavy constant mu |
3507 |
P01871 |
chr14: 105,851,708-105,856,218 |
|
HLA-B |
major histocompatibility complex, class I, B |
3106 |
P01889 |
chr6: 31,269,491-31,357,188 |
|
HLA-H |
major histocompatibility complex, class I, H (pseudogene) |
3136 |
P01893 |
chr6: 29,879,053-29,881,769 |
|
HLA-DRA |
major histocompatibility complex, class II, DR alpha |
3122 |
P01903 |
chr6: 32,439,842-32,445,046 |
|
HLA-DQA2 |
major histocompatibility complex, class II, DQ alpha 2 |
3118 |
P01906 |
chr6: 32,741,342-32,747,215 |
|
HLA-DQA1 |
major histocompatibility complex, class II, DQ alpha 1 |
3117 |
P01909 |
chr6: 32,628,179-32,647,062 |
|
HLA-DQB1 |
major histocompatibility complex, class II, DQ beta 1 |
3119 |
P01920 |
chr6: 32,659,467-32,668,383 |
|
FN1 |
fibronectin 1 |
2335 |
P02751 |
chr2: 215,360,440-215,436,172 |
|
A1BG |
alpha-1-B glycoprotein |
1 |
P04217 |
chr19: 58,345,178-58,353,499 |
|
HLA-DRB1 |
major histocompatibility complex, class II, DR beta 1 |
3123 |
P04229 |
chr6: 32,578,769-32,589,848 |
|
NTRK1 |
neurotrophic tyrosine kinase, receptor, type 1 |
4914 |
P04629 |
chr1: 156,815,640-156,881,850 |
|
ICAM1 |
intercellular adhesion molecule 1 |
3383 |
P05362 |
chr19: 10,270,835-10,286,615 |
|
INSR |
insulin receptor |
3643 |
P06213 |
chr19: 7,112,255-7,294,034 |
|
CSF1R |
colony stimulating factor 1 receptor |
1436 |
P07333 |
chr5: 150,053,291-150,113,372 |
|
IGF1R |
insulin like growth factor 1 receptor |
3480 |
P08069 |
chr15: 98,648,971-98,964,530 |
|
PTPRC |
protein tyrosine phosphatase, receptor type, C |
5788 |
P08575 |
chr1: 198,638,671-198,757,283 |
|
MET |
MET proto-oncogene, receptor tyrosine kinase |
4233 |
P08581 |
chr7: 116,672,390-116,798,386 |
|
IL6R |
interleukin 6 receptor |
3570 |
P08887 |
chr1: 154,405,193-154,469,450 |
|
CD48 |
CD48 molecule |
962 |
P09326 |
chr1: 160,678,746-160,711,851 |
|
PDGFRB |
platelet-derived growth factor receptor, beta polypeptide |
5159 |
P09619 |
chr5: 150,113,837-150,155,872 |
|
C4A |
complement component 4A (Rodgers blood group) |
720 |
P0C0L4 |
chr6: 31,982,024-32,002,681 |
|
C4B |
complement component 4B (Chido blood group) |
721 |
P0C0L5 |
chr6: 32,014,762-32,035,418 |
|
PTPRF |
protein tyrosine phosphatase, receptor type, F |
5792 |
P10586 |
chr1: 43,525,187-43,623,666 |
|
KIT |
v-kit Hardy-Zuckerman 4 feline sarcoma viral oncogene homolog |
3815 |
P10721 |
chr4: 54,657,918-54,740,715 |
|
CD28 |
CD28 molecule |
940 |
P10747 |
chr2: 203,706,475-203,738,912 |
|
GHR |
growth hormone receptor |
2690 |
P10912 |
chr5: 42,423,777-42,721,878 |
|
HAPLN1 |
hyaluronan and proteoglycan link protein 1 |
1404 |
P10915 |
chr5: 83,637,805-83,721,613 |
|
FGFR1 |
fibroblast growth factor receptor 1 |
2260 |
P11362 |
chr8: 38,411,138-38,468,834 |
|
COL6A3 |
collagen, type VI, alpha 3 |
1293 |
P12111 |
chr2: 237,324,003-237,414,375 |
|
FCGR1A |
Fc fragment of IgG, high affinity Ia, receptor (CD64) |
2209 |
P12314 |
chr1: 149,782,671-149,792,518 |
|
FCGR2A |
Fc fragment of IgG, low affinity IIa, receptor (CD32) |
2212 |
P12318 |
chr1: 161,505,430-161,524,013 |
|
NCAM1 |
neural cell adhesion molecule 1 |
4684 |
P13591 |
chr11: 112,961,247-113,278,436 |
|
VCAN |
versican |
1462 |
P13611 |
chr5: 83,471,465-83,582,303 |
|
HLA-E |
major histocompatibility complex, class I, E |
3133 |
P13747 |
chr6: 30,489,467-30,494,205 |
|
HLA-DRB4 |
major histocompatibility complex, class II, DR beta 4 |
3126 |
P13762 |
chr6: 32,542,598-32,557,561 |
|
HLA-DOB |
major histocompatibility complex, class II, DO beta |
3112 |
P13765 |
chr6: 32,812,763-32,817,048 |
|
IL1R1 |
interleukin 1 receptor, type I |
3554 |
P14778 |
chr2: 102,064,544-102,179,874 |
|
PVR |
poliovirus receptor |
5817 |
P15151 |
chr19: 44,643,798-44,663,583 |
|
IFNGR1 |
interferon gamma receptor 1 |
3459 |
P15260 |
chr6: 137,197,484-137,219,449 |
|
CD1D |
CD1d molecule |
912 |
P15813 |
chr1: 158,179,947-158,184,896 |
|
ACAN |
aggrecan |
176 |
P16112 |
chr15: 88,803,443-88,875,354 |
|
ITGB4 |
integrin subunit beta 4 |
3691 |
P16144 |
chr17: 75,721,328-75,757,818 |
|
PDGFRA |
platelet-derived growth factor receptor, alpha polypeptide |
5156 |
P16234 |
chr4: 54,229,097-54,298,247 |
|
PECAM1 |
platelet/endothelial cell adhesion molecule 1 |
5175 |
P16284 |
chr17: 64,319,415-64,413,776 |
|
PRLR |
prolactin receptor |
5618 |
P16471 |
chr5: 35,048,756-35,230,589 |
|
IL7R |
interleukin 7 receptor |
3575 |
P16871 |
chr5: 35,852,695-35,879,603 |
|
IFNAR1 |
interferon (alpha, beta and omega) receptor 1 |
3454 |
P17181 |
chr21: 33,324,477-33,359,862 |
|
HLA-G |
major histocompatibility complex, class I, G |
3135 |
P17693 |
chr6: 29,826,967-29,831,125 |
|
LAG3 |
lymphocyte-activation gene 3 |
3902 |
P18627 |
chr12: 6,772,512-6,778,455 |
|
EPOR |
erythropoietin receptor |
2057 |
P19235 |
chr19: 11,377,205-11,384,342 |
|
CD58 |
CD58 molecule |
965 |
P19256 |
chr1: 116,514,535-116,571,039 |
|
VCAM1 |
vascular cell adhesion molecule 1 |
7412 |
P19320 |
chr1: 100,719,742-100,739,045 |
|
NFKB1 |
nuclear factor of kappa light polypeptide gene enhancer in B-cells 1 |
4790 |
P19838 |
chr4: 102,501,329-102,617,302 |
|
HLA-DPA1 |
major histocompatibility complex, class II, DP alpha 1 |
3113 |
P20036 |
chr6: 33,064,569-33,080,775 |
|
CD33 |
CD33 molecule |
945 |
P20138 |
chr19: 51,225,064-51,243,860 |
|
MAG |
myelin associated glycoprotein |
4099 |
P20916 |
chr19: 35,292,125-35,313,804 |
|
FLNA |
filamin A |
2316 |
P21333 |
chrX: 154,348,524-154,374,638 |
|
FGFR2 |
fibroblast growth factor receptor 2 |
2263 |
P21802 |
chr10: 121,478,334-121,598,458 |
|
TGM2 |
transglutaminase 2 |
7052 |
P21980 |
chr20: 38,127,387-38,166,578 |
|
TNXB |
tenascin XB |
7148 |
P22105 |
chr6: 32,041,154-32,115,334 |
|
ANOS1 |
anosmin 1 |
3730 |
P23352 |
chrX: 8,528,874-8,732,186 |
|
PTPRB |
protein tyrosine phosphatase, receptor type, B |
5787 |
P23467 |
chr12: 70,515,866-70,637,440 |
|
PTPRD |
protein tyrosine phosphatase, receptor type, D |
5789 |
P23468 |
chr9: 8,314,246-10,612,723 |
|
PTPRG |
protein tyrosine phosphatase, receptor type, G |
5793 |
P23470 |
chr3: 61,561,569-62,297,613 |
|
IL4R |
interleukin 4 receptor |
3566 |
P24394 |
chr16: 27,313,668-27,364,778 |
|
TNC |
tenascin C |
3371 |
P24821 |
chr9: 115,019,578-115,118,257 |
|
AZGP1 |
alpha-2-glycoprotein 1, zinc-binding |
563 |
P25311 |
chr7: 99,966,720-99,976,157 |
|
IL1R2 |
interleukin 1 receptor, type II |
7850 |
P27930 |
chr2: 101,991,844-102,028,544 |
|
HLA-DMA |
major histocompatibility complex, class II, DM alpha |
3108 |
P28067 |
chr6: 32,948,613-32,969,094 |
|
HLA-DMB |
major histocompatibility complex, class II, DM beta |
3109 |
P28068 |
chr6: 32,934,629-32,941,070 |
|
LOX |
lysyl oxidase |
4015 |
P28300 |
chr5: 122,063,195-122,078,360 |
|
PTPRM |
protein tyrosine phosphatase, receptor type, M |
5797 |
P28827 |
chr18: 7,566,782-8,406,861 |
|
EPHA3 |
EPH receptor A3 |
2042 |
P29320 |
chr3: 89,107,524-89,482,134 |
|
EPHB2 |
EPH receptor B2 |
2048 |
P29323 |
chr1: 22,710,839-22,921,500 |
|
HLA-A |
major histocompatibility complex, class I, A |
3105 |
P30443 |
chr6: 29,941,260-29,945,884 |
|
HLA-C |
major histocompatibility complex, class I, C |
3107 |
P30499 |
chr6: 31,268,749-31,272,130 |
|
HLA-F |
major histocompatibility complex, class I, F |
3134 |
P30511 |
chr6: 29,722,775-29,738,528 |
|
FCGR2B |
Fc fragment of IgG, low affinity IIb, receptor (CD32) |
2213 |
P31994 |
chr1: 161,663,147-161,678,654 |
|
TIE1 |
tyrosine kinase with immunoglobulin-like and EGF-like domains 1 |
7075 |
P35590 |
chr1: 43,300,993-43,323,108 |
|
BSG |
basigin (Ok blood group) |
682 |
P35613 |
chr19: 571,277-583,493 |
|
FLT4 |
fms-related tyrosine kinase 4 |
2324 |
P35916 |
chr5: 180,601,506-180,649,624 |
|
IFNGR2 |
interferon gamma receptor 2 (interferon gamma transducer 1) |
3460 |
P38484 |
chr21: 33,402,896-33,479,348 |
|
IL6ST |
interleukin 6 signal transducer |
3572 |
P40189 |
chr5: 55,935,095-55,994,993 |
|
PMEL |
premelanosome protein |
6490 |
P40967 |
chr12: 55,954,105-55,973,317 |
|
CD200 |
CD200 molecule |
4345 |
P41217 |
chr3: 112,332,347-112,362,812 |
|
IL12RB1 |
interleukin 12 receptor subunit beta 1 |
3594 |
P42701 |
chr19: 18,058,995-18,098,944 |
|
LIFR |
leukemia inhibitory factor receptor alpha |
3977 |
P42702 |
chr5: 38,474,963-38,608,354 |
|
MCAM |
melanoma cell adhesion molecule |
4162 |
P43121 |
chr11: 119,308,529-119,321,521 |
|
KIR3DL2 |
killer cell immunoglobulin-like receptor, three domains, long cytoplasmic tail, 2 |
3812 |
P43630 |
chr19: 54,850,443-54,867,207 |
|
LEPR |
leptin receptor |
3953 |
P48357 |
chr1: 65,420,652-65,641,559 |
|
IFNAR2 |
interferon (alpha, beta and omega) receptor 2 |
3455 |
P48551 |
chr21: 33,229,901-33,265,675 |
|
TGM4 |
transglutaminase 4 |
7047 |
P49221 |
chr3: 44,874,608-44,914,990 |
|
BCAM |
basal cell adhesion molecule (Lutheran blood group) |
4059 |
P50895 |
chr19: 44,809,059-44,821,420 |
|
PLXNA3 |
plexin A3 |
55558 |
P51805 |
chrX: 154,458,281-154,477,779 |
|
EPHA5 |
EPH receptor A5 |
2044 |
P54756 |
chr4: 65,319,563-65,670,495 |
|
EPHB4 |
EPH receptor B4 |
2050 |
P54760 |
chr7: 100,802,565-100,827,521 |
|
EPHB1 |
EPH receptor B1 |
2047 |
P54762 |
chr3: 134,597,801-135,260,467 |
|
EPHA4 |
EPH receptor A4 |
2043 |
P54764 |
chr2: 221,418,027-221,574,202 |
|
MFAP3 |
microfibrillar associated protein 3 |
4238 |
P55082 |
chr5: 154,038,906-154,220,478 |
|
JAM2 |
junctional adhesion molecule 2 |
58494 |
P57087 |
chr21: 25,639,272-25,717,562 |
|
ANTXR2 |
anthrax toxin receptor 2 |
118429 |
P58335 |
chr4: 79,901,149-80,125,454 |
|
B2M |
beta-2-microglobulin |
567 |
P61769 |
chr15: 44,711,477-44,718,877 |
|
CXADR |
coxsackie virus and adenovirus receptor |
1525 |
P78310 |
chr21: 17,512,382-17,593,579 |
|
SIRPA |
signal-regulatory protein alpha |
140885 |
P78324 |
chr20: 1,894,167-1,940,592 |
|
BTN3A2 |
butyrophilin subfamily 3 member A2 |
11118 |
P78410 |
chr6: 26,365,159-26,378,320 |
|
HLA-DRB3 |
major histocompatibility complex, class II, DR beta 3 |
3125 |
P79483 |
chr6: 32,444,128-32,457,245 |
|
HSPG2 |
heparan sulfate proteoglycan 2 |
3339 |
P98160 |
chr1: 21,822,245-21,937,297 |
|
PKD1 |
polycystic kidney disease 1 (autosomal dominant) |
5310 |
P98161 |
chr16: 2,088,710-2,135,898 |
|
MYBPC1 |
myosin binding protein C, slow type |
4604 |
Q00872 |
chr12: 101,568,353-101,686,018 |
|
IL9R |
interleukin 9 receptor |
3581 |
Q01113 |
chrX: 155,997,581-156,010,817 |
|
CD83 |
CD83 molecule |
9308 |
Q01151 |
chr6: 14,117,256-14,136,918 |
|
RELB |
v-rel avian reticuloendotheliosis viral oncogene homolog B |
5971 |
Q01201 |
chr19: 45,001,430-45,038,198 |
|
IL5RA |
interleukin 5 receptor subunit alpha |
3568 |
Q01344 |
chr3: 3,066,326-3,126,613 |
|
IL1RL1 |
interleukin 1 receptor-like 1 |
9173 |
Q01638 |
chr2: 102,311,502-102,352,037 |
|
OCRL |
oculocerebrorenal syndrome of Lowe |
4952 |
Q01968 |
chrX: 129,539,849-129,592,561 |
|
ROR1 |
receptor tyrosine kinase-like orphan receptor 1 |
4919 |
Q01973 |
chr1: 63,774,022-64,181,498 |
|
NRG1 |
neuregulin 1 |
3084 |
Q02297 |
chr8: 31,639,386-32,767,959 |
|
TEK |
TEK tyrosine kinase, endothelial |
7010 |
Q02763 |
chr9: 27,109,141-27,230,175 |
|
RELA |
v-rel avian reticuloendotheliosis viral oncogene homolog A |
5970 |
Q04206 |
chr11: 65,653,596-65,663,094 |
|
GBE1 |
glucan (1,4-alpha-), branching enzyme 1 |
2632 |
Q04446 |
chr3: 81,489,699-81,762,161 |
|
REL |
v-rel avian reticuloendotheliosis viral oncogene homolog |
5966 |
Q04864 |
chr2: 60,881,521-60,931,610 |
|
COL14A1 |
collagen, type XIV, alpha 1 |
7373 |
Q05707 |
chr8: 120,059,780-120,372,036 |
|
TYRO3 |
TYRO3 protein tyrosine kinase |
7301 |
Q06418 |
chr15: 41,557,675-41,583,586 |
|
IL10RB |
interleukin 10 receptor subunit beta |
3588 |
Q08334 |
chr21: 33,266,358-33,310,187 |
|
LOXL1 |
lysyl oxidase like 1 |
4016 |
Q08397 |
chr15: 73,925,989-73,952,137 |
|
CD47 |
CD47 molecule |
961 |
Q08722 |
chr3: 108,043,298-108,091,025 |
|
NEXN |
nexilin (F actin binding protein) |
91624 |
Q0ZGT2 |
chr1: 77,888,513-77,943,895 |
|
CNTN1 |
contactin 1 |
1272 |
Q12860 |
chr12: 40,692,442-41,072,418 |
|
MERTK |
MER proto-oncogene, tyrosine kinase |
10461 |
Q12866 |
chr2: 111,898,479-112,029,561 |
|
PTPRJ |
protein tyrosine phosphatase, receptor type, J |
5795 |
Q12913 |
chr11: 47,980,558-48,170,841 |
|
PSG7 |
pregnancy specific beta-1-glycoprotein 7 (gene/pseudogene) |
5676 |
Q13046 |
chr19: 42,924,132-42,937,178 |
|
SEMA3B |
sema domain, immunoglobulin domain (Ig), short basic domain, secreted, (semaphorin) 3B |
7869 |
Q13214 |
chr3: 50,267,558-50,277,546 |
|
PAPPA |
pregnancy-associated plasma protein A, pappalysin 1 |
5069 |
Q13219 |
chr9: 116,153,804-116,402,322 |
|
PTK7 |
protein tyrosine kinase 7 (inactive) |
5754 |
Q13308 |
chr6: 43,076,268-43,161,719 |
|
LSAMP |
limbic system-associated membrane protein |
4045 |
Q13449 |
chr3: 115,802,363-117,139,389 |
|
NFATC2 |
nuclear factor of activated T-cells, cytoplasmic, calcineurin-dependent 2 |
4773 |
Q13469 |
chr20: 51,386,957-51,562,831 |
|
IL18R1 |
interleukin 18 receptor 1 |
8809 |
Q13478 |
chr2: 102,311,529-102,398,775 |
|
ALCAM |
activated leukocyte cell adhesion molecule |
214 |
Q13740 |
chr3: 105,366,909-105,576,900 |
|
CEACAM7 |
carcinoembryonic antigen-related cell adhesion molecule 7 |
1087 |
Q14002 |
chr19: 41,673,307-41,706,976 |
|
DAG1 |
dystroglycan 1 |
1605 |
Q14118 |
chr3: 49,468,703-49,535,618 |
|
DSG2 |
desmoglein 2 |
1829 |
Q14126 |
chr18: 31,498,043-31,549,008 |
|
FLNC |
filamin C |
2318 |
Q14315 |
chr7: 128,830,377-128,859,274 |
|
SEMA3A |
sema domain, immunoglobulin domain (Ig), short basic domain, secreted, (semaphorin) 3A |
10371 |
Q14563 |
chr7: 83,955,777-84,492,724 |
|
NFATC4 |
nuclear factor of activated T-cells, cytoplasmic, calcineurin-dependent 4 |
4776 |
Q14934 |
chr14: 24,365,673-24,379,604 |
|
GPNMB |
glycoprotein (transmembrane) nmb |
10457 |
Q14956 |
chr7: 23,235,967-23,275,108 |
|
CLCA4 |
chloride channel accessory 4 |
22802 |
Q14CN2 |
chr1: 86,547,078-86,580,754 |
|
NECTIN1 |
poliovirus receptor-related 1 (herpesvirus entry mediator C) |
5818 |
Q15223 |
chr11: 119,623,408-119,729,084 |
|
PTPRK |
protein tyrosine phosphatase, receptor type, K |
5796 |
Q15262 |
chr6: 127,968,779-128,520,674 |
|
GUSBP1 |
glucuronidase, beta pseudogene 1 |
728411 |
Q15486 |
chr5: 21,341,833-21,589,372 |
|
MYLK |
myosin light chain kinase |
4638 |
Q15746 |
chr3: 123,610,049-123,884,331 |
|
IGFBP7 |
insulin like growth factor binding protein 7 |
3490 |
Q16270 |
chr4: 57,030,773-57,110,385 |
|
TNXA |
tenascin XA (pseudogene) |
7146 |
Q16473 |
chr6: 32,085,057-32,088,915 |
|
PSG3 |
pregnancy specific beta-1-glycoprotein 3 |
5671 |
Q16557 |
chr19: 42,721,638-42,740,569 |
|
NTRK2 |
neurotrophic tyrosine kinase, receptor, type 2 |
4915 |
Q16620 |
chr9: 84,668,551-85,027,070 |
|
PPP1R3A |
protein phosphatase 1 regulatory subunit 3A |
5506 |
Q16821 |
chr7: 113,876,777-114,075,920 |
|
PTPRO |
protein tyrosine phosphatase, receptor type, O |
5800 |
Q16827 |
chr12: 15,322,397-15,597,399 |
|
MICB |
MHC class I polypeptide-related sequence B |
4277 |
Q29980 |
chr6: 31,494,881-31,511,124 |
|
MICA |
MHC class I polypeptide-related sequence A |
100507436 |
Q29983 |
chr6: 31,399,784-31,415,315 |
|
HLA-DRB5 |
major histocompatibility complex, class II, DR beta 5 |
3127 |
Q30154 |
chr6: 32,517,343-32,530,287 |
|
HFE |
hemochromatosis |
3077 |
Q30201 |
chr6: 26,087,281-26,098,343 |
|
CEACAM21 |
carcinoembryonic antigen-related cell adhesion molecule 21 |
90273 |
Q3KPI0 |
chr19: 41,549,518-41,586,844 |
|
FNDC3B |
fibronectin type III domain containing 3B |
64778 |
Q53EP0 |
chr3: 172,039,628-172,401,665 |
|
SDK2 |
sidekick cell adhesion molecule 2 |
54549 |
Q58EX2 |
chr17: 73,334,384-73,644,089 |
|
IGSF11 |
immunoglobulin superfamily member 11 |
152404 |
Q5DX21 |
chr3: 118,900,557-119,146,068 |
|
CD276 |
CD276 molecule |
80381 |
Q5ZPR3 |
chr15: 73,683,966-73,714,518 |
|
LAIR1 |
leukocyte-associated immunoglobulin-like receptor 1 |
3903 |
Q6GTX8 |
chr19: 54,351,384-54,370,558 |
|
SIGIRR |
single immunoglobulin and toll-interleukin 1 receptor (TIR) domain |
59307 |
Q6IA17 |
chr11: 405,716-417,455 |
|
OVOS2 |
ovostatin 2 |
144203 |
Q6IE36 |
chr12: 31,111,652-31,206,154 |
|
OVOS1 |
ovostatin |
408186 |
Q6IE37 |
chr12: 31,111,652-31,206,154 |
|
LAIR2 |
leukocyte-associated immunoglobulin-like receptor 2 |
3904 |
Q6ISS4 |
chr19: 54,497,879-54,510,687 |
|
PTCRA |
pre T-cell antigen receptor alpha |
171558 |
Q6ISU1 |
chr6: 42,915,989-42,925,835 |
|
CSPG4 |
chondroitin sulfate proteoglycan 4 |
1464 |
Q6UVK1 |
chr15: 75,674,322-75,712,848 |
|
KDELC1 |
KDEL motif containing 1 |
79070 |
Q6UW63 |
chr13: 102,784,281-102,799,007 |
|
LRRN1 |
leucine rich repeat neuronal 1 |
57633 |
Q6UXK5 |
chr3: 3,799,437-3,847,703 |
|
LRIG3 |
leucine-rich repeats and immunoglobulin-like domains 3 |
121227 |
Q6UXM1 |
chr12: 58,872,149-58,920,522 |
|
ATF7IP |
activating transcription factor 7 interacting protein |
55729 |
Q6VMQ6 |
chr12: 14,365,632-14,502,935 |
|
CCDC141 |
coiled-coil domain containing 141 |
285025 |
Q6ZP82 |
chr2: 178,830,269-179,050,086 |
|
PPP1R3F |
protein phosphatase 1 regulatory subunit 3F |
89801 |
Q6ZSY5 |
chrX: 49,269,843-49,301,461 |
|
CFAP47 |
cilia and flagella associated protein 47 |
286464 |
Q6ZTR5 |
chrX: 35,919,734-36,385,319 |
|
ILDR2 |
immunoglobulin-like domain containing receptor 2 |
387597 |
Q71H61 |
chr1: 166,895,711-166,975,482 |
|
BTN2A1 |
butyrophilin subfamily 2 member A1 |
11120 |
Q7KYR7 |
chr6: 26,457,904-26,476,621 |
|
LINGO2 |
leucine rich repeat and Ig domain containing 2 |
158038 |
Q7L985 |
chr9: 27,948,078-28,670,286 |
|
KDELC2 |
KDEL motif containing 2 |
143888 |
Q7Z4H8 |
chr11: 108,472,105-108,498,432 |
|
SDK1 |
sidekick cell adhesion molecule 1 |
221935 |
Q7Z5N4 |
chr7: 3,301,448-4,269,000 |
|
VTCN1 |
V-set domain containing T cell activation inhibitor 1 |
79679 |
Q7Z7D3 |
chr1: 117,143,587-117,210,960 |
|
PKHD1L1 |
polycystic kidney and hepatic disease 1 (autosomal recessive)-like 1 |
93035 |
Q86WI1 |
chr8: 109,362,477-109,530,330 |
|
LSR |
lipolysis stimulated lipoprotein receptor |
51599 |
Q86X29 |
chr19: 35,248,330-35,267,964 |
|
PPP1R3B |
protein phosphatase 1 regulatory subunit 3B |
79660 |
Q86XI6 |
chr8: 9,136,255-9,151,574 |
|
CRLF3 |
cytokine receptor-like factor 3 |
51379 |
Q8IUI8 |
chr17: 30,769,388-30,824,776 |
|
VSTM4 |
V-set and transmembrane domain containing 4 |
196740 |
Q8IW00 |
chr10: 49,014,245-49,115,509 |
|
ADGRA3 |
adhesion G protein-coupled receptor A3 |
166647 |
Q8IWK6 |
chr4: 22,345,071-22,516,054 |
|
CNTN4 |
contactin 4 |
152330 |
Q8IWV2 |
chr3: 2,098,813-3,057,956 |
|
TRIM42 |
tripartite motif containing 42 |
287015 |
Q8IWZ5 |
chr3: 140,678,039-140,701,150 |
|
KIAA0319L |
KIAA0319-like |
79932 |
Q8IZA0 |
chr1: 35,433,490-35,557,950 |
|
UNC5B |
unc-5 netrin receptor B |
219699 |
Q8IZJ1 |
chr10: 71,212,570-71,302,864 |
|
CPAMD8 |
C3 and PZP-like, alpha-2-macroglobulin domain containing 8 |
27151 |
Q8IZJ3 |
chr19: 16,892,947-17,026,815 |
|
ASPM |
abnormal spindle microtubule assembly |
259266 |
Q8IZT6 |
chr1: 197,084,128-197,146,694 |
|
CMYA5 |
cardiomyopathy associated 5 |
202333 |
Q8N3K9 |
chr5: 79,689,877-79,800,240 |
|
POMGNT2 |
protein O-linked mannose N-acetylglucosaminyltransferase 2 (beta 1,4-) |
84892 |
Q8NAT1 |
chr3: 43,079,232-43,106,076 |
|
LILRB1 |
leukocyte immunoglobulin-like receptor, subfamily B (with TM and ITIM domains), member 1 |
10859 |
Q8NHL6 |
chr19: 54,617,158-54,637,528 |
|
MOSPD2 |
motile sperm domain containing 2 |
158747 |
Q8NHP6 |
chrX: 14,873,441-14,922,327 |
|
NDNF |
neuron-derived neurotrophic factor |
79625 |
Q8TB73 |
chr4: 121,035,613-121,073,021 |
|
IGDCC4 |
immunoglobulin superfamily, DCC subclass, member 4 |
57722 |
Q8TDY8 |
chr15: 65,381,464-65,423,072 |
|
CEP192 |
centrosomal protein 192kDa |
55125 |
Q8TEP8 |
chr18: 12,991,362-13,125,052 |
|
SECTM1 |
secreted and transmembrane 1 |
6398 |
Q8WVN6 |
chr17: 82,321,024-82,334,074 |
|
BTN2A2 |
butyrophilin subfamily 2 member A2 |
10385 |
Q8WVV5 |
chr6: 26,383,096-26,394,874 |
|
PALLD |
palladin, cytoskeletal associated protein |
23022 |
Q8WX93 |
chr4: 168,497,066-168,928,457 |
|
TTN |
titin |
7273 |
Q8WZ42 |
chr2: 178,525,989-178,830,802 |
|
FCGR1B |
Fc fragment of IgG, high affinity Ib, receptor (CD64) |
2210 |
Q92637 |
chr1: 121,087,345-121,096,310 |
|
SORL1 |
sortilin-related receptor, L(DLR class) A repeats containing |
6653 |
Q92673 |
chr11: 121,452,203-121,633,693 |
|
TNR |
tenascin R |
7143 |
Q92752 |
chr1: 175,315,194-175,743,770 |
|
NRCAM |
neuronal cell adhesion molecule |
4897 |
Q92823 |
chr7: 108,147,623-108,456,717 |
|
MR1 |
major histocompatibility complex, class I-related |
3140 |
Q95460 |
chr1: 181,033,425-181,061,938 |
|
BCAN |
brevican |
63827 |
Q96GW7 |
chr1: 156,641,390-156,659,532 |
|
KAZALD1 |
Kazal-type serine peptidase inhibitor domain 1 |
81621 |
Q96I82 |
chr10: 101,061,841-101,068,131 |
|
VSIG2 |
V-set and immunoglobulin domain containing 2 |
23584 |
Q96IQ7 |
chr11: 124,747,472-124,752,238 |
|
LRIG1 |
leucine-rich repeats and immunoglobulin-like domains 1 |
26018 |
Q96JA1 |
chr3: 66,378,797-66,501,263 |
|
EXOC2 |
exocyst complex component 2 |
55770 |
Q96KP1 |
chr6: 485,133-693,111 |
|
FCRL1 |
Fc receptor-like 1 |
115350 |
Q96LA6 |
chr1: 157,794,403-157,820,105 |
|
ROBO3 |
roundabout guidance receptor 3 |
64221 |
Q96MS0 |
chr11: 124,865,386-124,881,470 |
|
VSTM2L |
V-set and transmembrane domain containing 2 like |
128434 |
Q96N03 |
chr20: 37,903,104-37,945,350 |
|
ERMAP |
erythroblast membrane-associated protein (Scianna blood group) |
114625 |
Q96PL5 |
chr1: 42,817,124-42,844,989 |
|
SIGLEC11 |
sialic acid binding Ig-like lectin 11 |
114132 |
Q96RL6 |
chr19: 49,948,985-49,961,172 |
|
CSF3R |
colony stimulating factor 3 receptor |
1441 |
Q99062 |
chr1: 36,466,043-36,483,278 |
|
OSMR |
oncostatin M receptor |
9180 |
Q99650 |
chr5: 38,845,858-38,945,596 |
|
COL12A1 |
collagen, type XII, alpha 1 |
1303 |
Q99715 |
chr6: 75,084,326-75,206,051 |
|
SEMA3C |
sema domain, immunoglobulin domain (Ig), short basic domain, secreted, (semaphorin) 3C |
10512 |
Q99985 |
chr7: 80,742,538-80,922,359 |
|
TMEM106C |
transmembrane protein 106C |
79022 |
Q9BVX2 |
chr12: 47,963,569-47,968,878 |
|
TAPBPL |
TAP binding protein-like |
55080 |
Q9BX59 |
chr12: 6,451,690-6,466,517 |
|
JAM3 |
junctional adhesion molecule 3 |
83700 |
Q9BX67 |
chr11: 134,068,925-134,152,001 |
|
FSD1L |
fibronectin type III and SPRY domain containing 1-like |
83856 |
Q9BXM9 |
chr9: 105,447,796-105,552,433 |
|
CADM1 |
cell adhesion molecule 1 |
23705 |
Q9BY67 |
chr11: 115,169,218-115,504,957 |
|
CD244 |
CD244 molecule, natural killer cell receptor 2B4 |
51744 |
Q9BZW8 |
chr1: 160,830,160-160,862,855 |
|
SIGLEC1 |
sialic acid binding Ig-like lectin 1, sialoadhesin |
6614 |
Q9BZZ2 |
chr20: 3,686,970-3,707,128 |
|
TRIM9 |
tripartite motif containing 9 |
114088 |
Q9C026 |
chr14: 50,975,262-51,096,061 |
|
TRIM2 |
tripartite motif containing 2 |
23321 |
Q9C040 |
chr4: 153,152,342-153,339,320 |
|
LRRN3 |
leucine rich repeat neuronal 3 |
54674 |
Q9H3W5 |
chr7: 111,091,006-111,125,454 |
|
FNDC4 |
fibronectin type III domain containing 4 |
64838 |
Q9H6D8 |
chr2: 27,491,883-27,495,245 |
|
C10orf54 |
chromosome 10 open reading frame 54 |
64115 |
Q9H7M9 |
chr10: 71,747,559-71,773,498 |
|
EBF2 |
early B-cell factor 2 |
64641 |
Q9HAK2 |
chr8: 25,841,730-26,045,397 |
|
ROBO2 |
roundabout guidance receptor 2 |
6092 |
Q9HCK4 |
chr3: 75,906,695-77,649,964 |
|
PTPRH |
protein tyrosine phosphatase, receptor type, H |
5794 |
Q9HD43 |
chr19: 55,181,248-55,209,506 |
|
TREM1 |
triggering receptor expressed on myeloid cells 1 |
54210 |
Q9NP99 |
chr6: 41,267,926-41,286,719 |
|
IL1RAP |
interleukin 1 receptor accessory protein |
3556 |
Q9NPH3 |
chr3: 190,514,051-190,659,750 |
|
NECTIN3 |
poliovirus receptor-related 3 |
25945 |
Q9NQS3 |
chr3: 111,070,071-111,275,563 |
|
MXRA5 |
matrix-remodelling associated 5 |
25878 |
Q9NR99 |
chrX: 3,308,565-3,346,641 |
|
TMEM106B |
transmembrane protein 106B |
54664 |
Q9NUM4 |
chr7: 12,211,241-12,243,367 |
|
FLRT3 |
fibronectin leucine rich transmembrane protein 3 |
23767 |
Q9NZU0 |
chr20: 14,322,988-14,337,616 |
|
FLRT1 |
fibronectin leucine rich transmembrane protein 1 |
23769 |
Q9NZU1 |
chr11: 64,103,188-64,119,173 |
|
VAPA |
VAMP associated protein A |
9218 |
Q9P0L0 |
chr18: 9,914,002-9,960,021 |
|
SLAMF8 |
SLAM family member 8 |
56833 |
Q9P0V8 |
chr1: 159,826,750-159,837,249 |
|
CNTN3 |
contactin 3 |
5067 |
Q9P232 |
chr3: 74,262,568-74,521,140 |
|
MYOT |
myotilin |
9499 |
Q9UBF9 |
chr5: 137,867,791-137,887,851 |
|
EPHA6 |
EPH receptor A6 |
285220 |
Q9UF33 |
chr3: 96,814,581-97,752,460 |
|
PLXNA1 |
plexin A1 |
5361 |
Q9UIW2 |
chr3: 126,988,594-127,037,392 |
|
MOSPD1 |
motile sperm domain containing 1 |
56180 |
Q9UJG1 |
chrX: 134,887,626-134,915,267 |
|
PILRB |
paired immunoglobin-like type 2 receptor beta |
29990 |
Q9UKJ0 |
chr7: 100,352,176-100,367,733 |
|
PILRA |
paired immunoglobin-like type 2 receptor alpha |
29992 |
Q9UKJ1 |
chr7: 100,367,530-100,400,099 |
|
IGSF9B |
immunoglobulin superfamily member 9B |
22997 |
Q9UPX0 |
chr11: 133,908,564-133,956,985 |
|
VSIG4 |
V-set and immunoglobulin domain containing 4 |
11326 |
Q9Y279 |
chrX: 66,021,738-66,040,125 |
|
SIGLEC7 |
sialic acid binding Ig-like lectin 7 |
27036 |
Q9Y286 |
chr19: 51,142,299-51,153,526 |
|
PLXND1 |
plexin D1 |
23129 |
Q9Y4D7 |
chr3: 129,555,175-129,606,818 |
|
HCFC2 |
host cell factor C2 |
29915 |
Q9Y5Z7 |
chr12: 104,064,457-104,106,524 |
|
F11R |
F11 receptor |
50848 |
Q9Y624 |
chr1: 160,995,211-161,021,348 |
|
CAMTA1 |
calmodulin binding transcription activator 1 |
23261 |
Q9Y6Y1 |
chr1: 6,785,324-7,769,706 |